Clinical Trials in Texas

Showing 9121-9140 of 11,487 trials

Brexpiprazole (OPC-34712) as an Adjunctive Treatment in Adults With Major Depressive Disorder and Anxiety Symptoms

NCT02013531

The purpose of this study is to investigate the efficacy and safety of flexibly dosed adjunctive brexpiprazole treatment in subjects with major depressive disorder and anxiety symptoms, who are experiencing an inadequate selective serotonin reuptake inhibitor (SSRI)/serotonin norepinephrine reuptake inhibitor (SNRI) response.

Major Depressive DisorderAnxiety

Otsuka Pharmaceutical Development & Commercialization, Inc.37 participantsStarted Nov 2013

Tuscon, Arizona, United States • Garden Grove, California, United States • Oceanside, California, United States +18 more locations

COMPLETEDPhase 355 miles

Lurasidone HCL - A 6-week Phase 3 Study of Patients With Acute Schizophrenia.

NCT00790192

Lurasidone HCl is a compound being developed for the treatment of schizophrenia. This clinical study is designed to test the hypothesis that lurasidone is effective, tolerable, and safe as compared with quetiapine XR short term among acutely psychotic patients with chronic schizophrenia.

Schizophrenia

Sumitomo Pharma America, Inc.488 participantsStarted Oct 2008

Little Rock, Arkansas, United States • Little Rock, Arkansas, United States • Cerritos, California, United States +62 more locations

Brexpiprazole (OPC-34712) as an Adjunctive Treatment in Adults With Major Depressive Disorder and Anxiety Symptoms

Lurasidone HCL - A 6-week Phase 3 Study of Patients With Acute Schizophrenia.

Find Trials by Condition in Texas

Comparison of TAK-875 (Fasiglifam) With Placebo in Participants With Type 2 Diabetes

A 12 Week Treatment, Multi-center, Randomized, Double-blind, Parallel-group, Placebo and Active Controlled Study to Assess the Efficacy, Safety, and Tolerability of Indacaterol Maleate / Glycopyrronium Bromide in COPD Patients With Moderate to Severe Airflow Limitation.

Trial of Gemcitabine/Carboplatin With or Without Iniparib (SAR240550) (a PARP1 Inhibitor) in Subjects With Previously Untreated Stage IV Squamous Non-Small-Cell Lung Cancer (NSCLC)

Linagliptin as Add on Therapy to Empagliflozin 10 mg or 25 mg With Background Metformin in Patient With Type 2 Diabetes

Treatment of Prostate Cancer With Adjuvant Bevacizumab Plus Erlotinib

TMC278-TiDP6-C215: A Clinical Trial in Treatment Naive HIV-subjects Patients Comparing TMC278 to Efavirenz in Combination With 2 Nucleoside/Nucleotide Reverse Transcriptase Inhibitors

Coenzyme Q10 in Huntington's Disease (HD)

Safety and Efficacy of EVT 101 in Treatment-Resistant Depression

Chemotherapy With or Without Strontium-89 in Treating Patients With Prostate Cancer

Bioequivalence Study of IG-001 Versus Nab-paclitaxel in Metastatic or Locally Recurrent Breast Cancer

Medigus Ultrasonic Surgical Endostapler (MUSE) Registry

Cross-sectional Study for Identification and Description of Severe Asthma Patients

A Prospective, Multi-Center Study of the Bard® Denali™ Retrievable Inferior Vena Cava Filter System

Bioequipotency Study of Idrabiotaparinux and Idraparinux in Patients With Deep Venous Thrombosis of the Lower Limbs

A Long Term Extension Study Evaluating ACC-001 With QS-21 in Subjects With Mild to Moderate Alzheimer's Disease

Long-term, Safety and Tolerability Study of AFQ056 in Adolescent Patients With Fragile X Syndrome (Open-label)

Effect of NeuroAD on the Cognitive Function of Alzheimer Patients

A Study of Ocrelizumab in Participants With Follicular Non-Hodgkin's Lymphoma (NHL)